|
|
(8 intermediate revisions not shown) |
Line 1: |
Line 1: |
- | <!--- The Mission, Experiments ---> | + | <html> |
| + | <script type="text/javascript" src="https://2011.igem.org/Team:Bilkent_UNAM_Turkey/js/dropdowncontent.js?action=raw&ctype=text/css\"></script> |
| + | <link href='https://2011.igem.org/Team:Bilkent_UNAM_Turkey/css/tabbedContent.css?action=raw&ctype=text/css' rel='stylesheet' type='text/css'/> |
| + | <script type='text/javascript' src='http://ajax.googleapis.com/ajax/libs/jquery/1.3/jquery.min.js'></script> |
| + | <script type="text/javascript" src="https://2011.igem.org/Team:Bilkent_UNAM_Turkey/wordlist.js?action=raw&ctype=text/css\"></script> |
| | | |
- | {| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey|Home]]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Team|Team]]
| |
- | !align="center"|[https://igem.org/Team.cgi?year=2011&team_name=Bilkent_UNAM_Turkey Official Team Profile]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Project|Project]]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Parts|Parts Submitted to the Registry]]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Modeling|Modeling]]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Notebook|Notebook]]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Safety|Safety]]
| |
- | !align="center"|[[Team:Bilkent_UNAM_Turkey/Attributions|Attributions]]
| |
- | |}
| |
- |
| |
- | <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
| |
- | <head>
| |
- | <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
| |
- | <meta name="generator" content="MediaWiki 1.13.3" />
| |
- | <meta name="keywords" content="Team:Bilkent UNAM Turkey/Safety" />
| |
- | <link rel="shortcut icon" href="/favicon.ico" />
| |
- | <link rel="search" type="application/opensearchdescription+xml" href="/wiki/opensearch_desc.php" title="2011.igem.org (en)" />
| |
- | <link title="Creative Commons" type="application/rdf+xml" href="/wiki/index.php?title=Team:Bilkent UNAM Turkey/safety&action=creativecommons" rel="meta" />
| |
- | <link rel="copyright" href="http://creativecommons.org/licenses/by/3.0/" />
| |
- |
| |
- | <link rel="alternate" type="application/rss+xml" title="2010.igem.org RSS Feed" href="https://2010.igem.org/wiki/index.php?title=Special:RecentChanges&feed=rss" />
| |
- | <link rel="alternate" type="application/atom+xml" title="2010.igem.org Atom Feed" href="https://2010.igem.org/wiki/index.php?title=Special:RecentChanges&feed=atom" />
| |
- | <title>Team:Bilkent UNAM Turkey/Safety - 2011.igem.org</title>
| |
- | <style type="text/css" media="screen, projection">/*<![CDATA[*/
| |
- | @import "/wiki/skins/common/shared.css?164";
| |
- | @import "/wiki/skins/igem/main.css?164";
| |
- | /*]]>*/</style>
| |
- | <link rel="stylesheet" type="text/css" media="print" href="/wiki/skins/common/commonPrint.css?164" />
| |
- | <!--[if lt IE 5.5000]><style type="text/css">@import "/wiki/skins/igem/IE50Fixes.css?164";</style><![endif]-->
| |
- | <!--[if IE 5.5000]><style type="text/css">@import "/wiki/skins/igem/IE55Fixes.css?164";</style><![endif]-->
| |
- | <!--[if IE 6]><style type="text/css">@import "/wiki/skins/igem/IE60Fixes.css?164";</style><![endif]-->
| |
- |
| |
- | <!--[if IE 7]><style type="text/css">@import "/wiki/skins/igem/IE70Fixes.css?164";</style><![endif]-->
| |
- | <!--[if lt IE 7]><script type="text/javascript" src="/wiki/skins/common/IEFixes.js?164"></script>
| |
- | <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
| |
- |
| |
- | <script type= "text/javascript">/*<![CDATA[*/
| |
- | var skin = "igem";
| |
- | var stylepath = "/wiki/skins";
| |
- | var wgArticlePath = "/$1";
| |
- | var wgScriptPath = "/wiki";
| |
- | var wgScript = "/wiki/index.php";
| |
- | var wgVariantArticlePath = false;
| |
- | var wgActionPaths = [];
| |
- | var wgServer = "https://2010.igem.org";
| |
- | var wgCanonicalNamespace = "";
| |
- | var wgCanonicalSpecialPageName = false;
| |
- | var wgNamespaceNumber = 0;
| |
- | var wgMWSuggestTemplate = "https://2011.igem.org/wiki/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}";
| |
- | var wgDBname = "2011_igem_org";
| |
- | var wgSearchNamespaces = [0];
| |
- | var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
| |
- | var wgRestrictionEdit = [];
| |
- | var wgRestrictionMove = [];
| |
- | var wgAjaxWatch = {"watchMsg": "Watch", "unwatchMsg": "Unwatch", "watchingMsg": "Watching...", "unwatchingMsg": "Unwatching..."};
| |
- | /*]]>*/</script>
| |
- |
| |
- | <script type="text/javascript" src="/wiki/skins/common/wikibits.js?164"><!-- wikibits js --></script>
| |
- | <!-- Head Scripts -->
| |
- | <script type="text/javascript" src="/wiki/skins/common/ajax.js?164"></script>
| |
- | <script type="text/javascript" src="/wiki/skins/common/ajaxwatch.js?164"></script>
| |
- |
| |
- | <script type="text/javascript" src="/wiki/skins/common/mwsuggest.js?164"></script>
| |
- | <script type="text/javascript" src="/wiki/index.php?title=-&action=raw&smaxage=0&gen=js&useskin=igem"><!-- site js --></script>
| |
- | <style type="text/css">/*<![CDATA[*/
| |
- | @import "/wiki/index.php?title=MediaWiki:Common.css&usemsgcache=yes&action=raw&ctype=text/css&smaxage=18000";
| |
- | @import "/wiki/index.php?title=MediaWiki:Igem.css&usemsgcache=yes&action=raw&ctype=text/css&smaxage=18000";
| |
- | @import "/wiki/index.php?title=-&action=raw&gen=css&maxage=18000&smaxage=0&useskin=igem";
| |
- | /*]]>*/</style><!-- jQuery Javascript -->
| |
- | <script type='text/javascript' src ='/common/jquery-latest.min.js'></script>
| |
- | <script type='text/javascript' src ='/common/tablesorter/jquery.tablesorter.min.js'></script>
| |
- |
| |
- | <link rel='stylesheet' type='text/css' href='/common/tablesorter/themes/groupparts/style.css' />
| |
- | <link rel='stylesheet' type='text/css' href='/common/table_styles.css' />
| |
- | </head>
| |
- |
| |
- | <body class="mediawiki ns-0 ltr page-Bilkent_UNAM_Turkey/Safety">
| |
- | <div id="globalWrapper">
| |
- |
| |
- |
| |
- | </div> <!-- end p-logo -->
| |
- | <script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
| |
- |
| |
- |
| |
- |
| |
- |
| |
- |
| |
- |
| |
- | </div> <!-- close top-section-->
| |
- | <div id="content">
| |
- | <a name="top" id="top"></a>
| |
- | <h1 class="firstHeading">Team:Bilkent UNAM Turkey/safety</h1>
| |
- | <div id="bodyContent">
| |
- | <h3 id="siteSub" class="noprint">From 2011.igem.org</h3>
| |
- | <div id="contentSub"></div>
| |
- |
| |
- | <!--
| |
- | <div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>-->
| |
- | <!-- start content -->
| |
- | <p>
| |
| <style type="text/css"> | | <style type="text/css"> |
- | #p-logo>a>img { | + | #menubar li a { |
- | position: relative !important;
| + | color: white; |
- | left: -1px !important;
| + | |
| } | | } |
- | | + | #menubar.right-menu { |
- | #top-section { | + | margin-top: -15px; |
- | width: 952px !important;
| + | |
- | overflow: hidden;
| + | |
| } | | } |
- | | + | #menubar.left-menu { |
- | #globalWrapper { | + | top:0; |
- | padding-bottom: 0px;
| + | |
| } | | } |
- | | + | .right-menu ul { |
- | #footer-box { | + | border: none; |
- | width: 800px;
| + | } |
| + | #menubar { |
| + | top: 12px; |
| + | z-index: 25; |
| + | } |
| + | .left-menu noprint{ |
| + | top:0; |
| + | } |
| + | #content { |
| + | background-color: transparent; |
| + | } |
| + | .anchor{ |
| + | text-decoration: underline |
| } | | } |
| + | .pops{ |
| + | position:absolute; |
| + | visibility: hidden; |
| + | border: 9px solid black; |
| + | background: url(https://static.igem.org/mediawiki/2011/5/56/B.jpg) repeat-x left top; |
| + | width: 300px; |
| + | padding: 8px; |
| + | -webkit-border-radius: 8px; |
| + | -moz-border-radius: 8px; |
| + | border-radius: 8px; |
| | | |
- | | + | } |
- | #allcontent, #p-logo {
| + | body { |
- | width: 900px !important;
| + | width: 100%; |
| + | margin: 0 auto; |
| + | padding: 0; |
| + | font: trebuchet, verdana, arial, times new roman; |
| + | } |
| + | #home {overflow:auto;} |
| + | img[src*="/wiki/skins/common/images/wiki.png"] { |
| + | width: 0; |
| + | height:0px; |
| } | | } |
| | | |
| .firstHeading { | | .firstHeading { |
- | display:none;
| + | border: none; |
| + | display:none; |
| + | } |
| + | #catlinks { |
| + | display: none; |
| + | } |
| + | #search-controls { |
| + | display: none; |
| + | } |
| + | #footer-box { |
| + | bottom: 3px; |
| + | background-color: black; |
| + | padding:0px -15px -2px -15px; |
| + | z-index:999; |
| + | } |
| + | html{ |
| + | background-color:white; |
| + | } |
| + | #globalWrapper { |
| + | width: 100%; |
| + | height: 100%; |
| + | padding-right: 0pt; |
| + | padding-left: 0pt; |
| + | padding-bottom: 10px; |
| + | background-color: white; |
| + | background: url(https://static.igem.org/mediawiki/2011/5/56/B.jpg) repeat-x left top; |
| + | /*-webkit-background-size: cover; |
| + | -moz-background-size: cover; |
| + | -o-background-size: cover; |
| + | background-size: cover; |
| + | background-attachment: fixed; |
| + | background-position:center top; |
| + | background-repeat:no-repeat;*/ |
| + | font: 13px Tahoma, Arial, Helvetica, sans-serif; |
| + | position: absolute; |
| + | overflow: shown; |
| + | margin: 0 auto; |
| + | color: white; |
| + | } |
| + | #banner{ |
| + | position:fixed; |
| + | z-index:24; |
| } | | } |
| | | |
- | body {
| + | </style> |
- |
| + | |
- | background-image:none;
| + | |
- | background-position: center;
| + | |
- | background-repeat: no-repeat;
| + | |
- | background-attachment: fixed;
| + | |
- | margin-left: auto;
| + | |
- | margin-right: auto;
| + | |
- | font-family: Helvetica, Arial, sans-serif;
| + | |
- | width: 900px;
| + | |
- | }
| + | |
| | | |
- | table {
| + | <div class='slide_content'> |
- | color: #8970cf;
| + | |
- | font-family: Helvetica, Arial, sans-serif;
| + | |
- | }
| + | |
| | | |
- | #content {
| |
- | color: #8970cf;
| |
- | font-family: Helvetica, Arial, sans-serif;
| |
- | width: 950px;
| |
- | line-height: 1.2em;
| |
| | | |
- | }
| + | <!-- all content should be here--> |
| | | |
- | a {
| + | <h2>SAFETY AND SECURITY QUESTIONS</h2> |
- | text-decoration: none;
| + | <p> |
- | color: #7F5217;
| + | <h3>1. Would the materials used in your project and/or your final product pose:</h3> |
- | }
| + | <b>a. Risks to the safety and health of team members or others in the lab?</b> |
- |
| + | <i> |
- | a:visited{ | + | <br>Using hazardous materials always has risk to cause trouble for team and lab members. We always <br>use hoods and wearing lab coat, gloves, goggles are essential for an experiment. |
- | color:#660000;
| + | <br>We are working on two species one of them is Chlamydomonas reinhardtii which has no dangerous <br>effect on human health. |
- | text-decoration: none;
| + | <br></i> |
- | }
| + | <br><b>b. Risks to the safety and health of the general public if released by design or accident?</b> |
| + | <br><i>Chlamydomonas reinhardtii is a strain of algae and it can cause algal bloom that means it <br>overgrows in a water ecosystem and becomes poisonous for other species which live in same places. |
| + | <br></i> |
| + | <br><b>c. Risks to environmental quality if released by design or accident?</b> |
| + | <i> |
| + | <br>We have not checked modified organism is more competitive than natural strains in normal condition.<br> However, in TNT contaminated soil or water, modified alg is expected to live more competetively. |
| + | <br></i> |
| + | <br><b>d. Risks to security through malicious misuse by individuals, groups or states?</b> |
| + | <br><i>Our modified Chlamydomonas reinhardtii just degrade TNT and it could not use for terrorism <br>activity. Those two modified organism could not have ability to damage human health. Our facility <br>always has an active security system and it requires an identity card for enterance. |
| + | <h3>2.Please explain your responses (whether yes or no) to these questions.</h3> |
| + | <b>Specifically, are any parts or devices in your project associated with (or known to cause):</b> |
| + | <br>- pathogenicity, infectivity, or toxicity? |
| + | <br>No</i> |
| + | <br>- threats to environmental quality? |
| + | <br><i>No</i> |
| + | <br>- security concerns? |
| + | <br><i>No</i> |
| + | <br> <br> |
| + | <b>a. Explain how you addressed these issues in project design and while conducting laboratory work.</b><br> |
| + | <i>Algal species, including Chlamydomonas reinhardtii, are capable of causing wide-scale bloom events known <br>colloquially as red tides, with severe negative consequences to freshwater and marine environs.<br> Therefore, the algal strains used in our project are an environmental risk. Consequently, they are treated <br>as biological hazardous waste. All biological waste is disposed of according to standards of<br> the National Nanotechnology Research Center (UNAM). Briefly, cells were killed via 5% bleach and disposed to<br> a waste storage allocated for biological contaminants.</i> |
| + | <br><b><br>b. Describe and document safety, security, health and/or environmental issues as you submit your <br>parts to the Registry.</b> |
| + | <br><i>Our parts have not any safety, security and health issues. However, adding nfsI gene into algae <br>could make it more competitive than normal strains. It requires checking before releasing to <br>nature.</i> |
| + | <br><h3>3. Under what biosafety provisions will / do you operate? </h3> |
| + | <b>a. Does your institution have its own biosafety rules and if so what are they? Provide a link to <br>them online if possible. </b> |
| + | <br><i>Our institution have its own biosafety rules and it takes 19 page so we added a link below which <br>leads to institution’s safety committee page and it contains two link; one of them orientation <br>of our lab and other one is chemical disposal form. |
| + | <br></i>http://unam.bilkent.edu.tr/UNAM%20Laboratory%20Safety.html |
| + | <br> |
| + | <br><b>b. Does your institution have an Institutional Biosafety Committee or equivalent group? If yes, <br>have you discussed your project with them? Describe any concerns or changes that were made based <br>on this review. </b> |
| + | <br><i>We have a Laboratory Safety Committee; however, we did not discuss about our project because our <br>experiment contains standard cloning procedure, which has always done in the lab. |
| + | <br></i> |
| + | <br><b>c. Will / did you receive any biosafety and/or lab training before beginning your project? If <br>so, describe this training.</b> |
| + | <br><i>All team members participated in a short course on biosafety measures and were subsequently<br> administered a written test to evaluate their capacity to react to common laboratory accidents. Particularly relevant<br> to our project is the part concerning correct handling of carcinogens and procedures in case of their spillage,<br> as our project foresees no use of radioactive, highly combustible or strongly oxidizing materials (though training <br>on safety protocols regarding those hazards was also provided).</i> |
| + | <br><br><b>d. Does your country have national biosafety regulations or guidelines? If so, provide a link to <br>them online if possible.</b> |
| + | <br />http://www.unep.org/biosafety/files/TRNBFrep.pdf |
| | | |
- | a:hover {
| |
- | color: #A0C500;
| |
- | text-decoration: none;
| |
- | }
| |
| | | |
- |
| + | <!-- up to here --> |
- | h1, h2, h3, h4, h5, h6 {
| + | |
- | color: #254117;
| + | |
- | }
| + | |
| | | |
- | #headerlinks{
| |
- | margin-left: -20px;
| |
- | }
| |
| | | |
- | #nav, #nav ul {
| |
- | padding: 0;
| |
- | list-style: none;
| |
- | }
| |
| | | |
- | .abstractext{
| + | </div> |
- | float:right;
| + | <div class='popingProblem' id='popingProblem' >There is a problem with poping up if you see this note.</div> <!-- dont delete this line, it is mandatory for poping up --> |
- | width="400px"
| + | |
- | }
| + | |
| | | |
- | #nav a {
| |
- | display: block;
| |
- | width: 149px;
| |
- | }
| |
| | | |
- | #nav li {
| |
- | float: left;
| |
- | width: 149px;
| |
- | margin-right: 41px;
| |
- | }
| |
| | | |
- | #nav li ul {
| |
- | position: absolute;
| |
- | width: 149px;
| |
- | left: -999em;
| |
- | }
| |
| | | |
- | #nav li:hover ul {
| |
- | left: auto;
| |
- | text-decoration: none;
| |
- | color: white !important;
| |
| | | |
- | }
| |
| | | |
- | #nav li:hover ul, #nav li.sfhover ul {
| |
- | left: auto;
| |
- | text-decoration: none;
| |
- | color: white !important;
| |
- | }
| |
| | | |
- | sfHover = function() {
| |
- | var sfEls = document.getElementById("nav").getElementsByTagName("LI");
| |
- | for (var i=0; i<sfEls.length; i++) {
| |
- | sfEls[i].onmouseover=function() {
| |
- | this.className+=" sfhover";
| |
- | }
| |
- | sfEls[i].onmouseout=function() {
| |
- | this.className=this.className.replace(new RegExp(" sfhover\\b"), "");
| |
- | }
| |
- | }
| |
- | }
| |
- | if (window.attachEvent) window.attachEvent("onload", sfHover);
| |
- |
| |
- | .bannerimage {
| |
- |
| |
- | }
| |
| | | |
- | a.bannerlinks {
| |
- | color: white !important;
| |
- | text-decoration: none;
| |
- | }
| |
| | | |
| | | |
- | a.bannertoplinks {
| |
- | color: white !important;
| |
- | text-decoration: none;
| |
- | }
| |
| | | |
- | a.bannerlinks:hover, a.bannertoplinks:hover {
| |
- | background-color: #A0C544;
| |
- | color: white;
| |
- | }
| |
| | | |
- | a.labnotebook{
| + | <script type="text/javascript"> |
- | color: #254117;
| + | for(var i =0;i<list.length;i++){ |
- | text-decoration: none;
| + | var temp=list[i]; |
- | }
| + | $("div.slide_content").html($("div.slide_content").html().replace( temp, "<a class=\"anchor\" href=\"https://2011.igem.org/Team:Bilkent_UNAM_Turkey/"+temp+"\" id=\"searchlink"+i+"\" rel=\"subcontent"+i+"\" rev=\"https://2011.igem.org/Team:Bilkent_UNAM_Turkey/pops/"+temp+"?action=raw&ctype=text/css\">"+temp+"</a>" )); |
- | | + | |
- | a.labnotebook:hover{ | + | |
- | color: #254117;
| + | |
- | text-decoration: none;
| + | |
| } | | } |
- | a.labnotebook:visited{
| |
- | color: #254117;
| |
- | text-decoration: none;
| |
- | }
| |
- |
| |
- | .bannerlinks {
| |
- | background-color: #7F5217;
| |
- | border-style: solid;
| |
- | border-color: white;
| |
- | border-width: 1px;
| |
- | color: white;
| |
- | padding: 3px 20px 3px 20px;
| |
- | margin-left: -19px;
| |
- | }
| |
| | | |
- | .bannertoplinks {
| |
- | background-color: #827B60;
| |
- | border-style: solid;
| |
- | border-color: white;
| |
- | border-width: 1px;
| |
- | color: white;
| |
- | margin-bottom: -2px;
| |
- | padding: 3px 20px 3px 20px;
| |
- | }
| |
- | .bannertoplinkslast{
| |
- | background-color: #827B60;
| |
- | border-style: solid;
| |
- | border-color: white;
| |
- | border-width: 1px;
| |
- | color: white;
| |
- | margin-bottom: -2px;
| |
- | padding: 3px 20px 3px 20px;
| |
- | }
| |
| | | |
- | #twitter_div {
| + | //this is for banner |
- | font-size: 0.8em;
| + | |
- | margin-right: 0px;
| + | |
- | }
| + | |
| | | |
- | #twitter_div ul {
| |
- | line-height: 1.3em;
| |
- | list-style-type: none;
| |
- | }
| |
| | | |
- | #twitter_div img {
| + | var tr1 = document.createElement('tr'); |
- | float: left;
| + | var table1 = document.createElement('table'); |
- | margin-top:.5em;
| + | table1.setAttribute('id','banner'); |
- | margin-right:.5em;
| + | |
- | }
| + | |
| | | |
- | #twitter_update_list {
| |
- | margin-left: 0px;
| |
- | }
| |
| | | |
- | #twitter_head {
| + | var image1 = document.createElement('img'); |
- | margin-bottom: .6em;
| + | image1.setAttribute('src', 'https://static.igem.org/mediawiki/2011/a/a1/Unam.gif'); |
- | border-bottom: 1px solid #AAA;
| + | image1.setAttribute('style','border:0;'); |
- | font-size: 150%;
| + | |
- | }
| + | |
| | | |
- | #twitter_head p {layout:block; margin-bottom:2px;}
| + | var image2 = document.createElement('img'); |
- | #twitter_head a {float:right; layout:block;}
| + | image2.setAttribute('src', 'https://static.igem.org/mediawiki/2011/0/05/Igem.gif'); |
| + | image2.setAttribute('style','border:0;'); |
| | | |
- | #sidebar {
| + | var image3 = document.createElement('img'); |
- | right:5px;
| + | image3.setAttribute('src', 'https://static.igem.org/mediawiki/2011/0/06/But.gif'); |
- | width: 300px;
| + | image3.setAttribute('style','border:0;'); |
- | float: right;
| + | |
- | margin-right: 0px;
| + | |
- | border: none;
| + | |
- | padding: 0px;
| + | |
- | padding-top:5px;
| + | |
- | }
| + | |
| | | |
- | #abstract {
| + | var image4 = document.createElement('img'); |
- | width: 600px;
| + | image4.setAttribute('src', 'https://static.igem.org/mediawiki/2011/3/32/Bilkent.gif'); |
- | border-style: solid;
| + | image4.setAttribute('style','border:0;'); |
- | border-color: white;
| + | |
- | border-width: 1px;
| + | |
- | padding: 10px;
| + | |
- | line-height: 1.2em;
| + | |
- | font-size: 14px;
| + | |
- | }
| + | |
- |
| + | |
- |
| + | |
- | #rightgroup {
| + | |
- | float: right;
| + | |
- | width: 300px;
| + | |
- | padding: 10px;
| + | |
- | }
| + | |
- |
| + | |
- | #leftgroup {
| + | |
- | width: 300px;
| + | |
- | padding: 10px;
| + | |
- | margin-right: 20px;
| + | |
- | }
| + | |
- |
| + | |
- | #maincontent {
| + | |
- | width: 610px;
| + | |
- | }
| + | |
| | | |
- | #headerlinks > #nav > li {
| + | var href1 = document.createElement('a'); |
- | border-bottom: 4px solid white;
| + | href1.setAttribute('href','http://www.nano.org.tr/index1.html'); |
- | }
| + | |
| | | |
- | #sidebar a{
| + | var href2 = document.createElement('a'); |
- | text-decoration: none;
| + | href2.setAttribute('href','https://2011.igem.org/Main_Page'); |
- | color: #7F5217;
| + | |
- | }
| + | |
| | | |
- | #sidebar a:hover{
| + | var href3 = document.createElement('a'); |
- | color: #A0C544;
| + | href3.setAttribute('href','https://2011.igem.org/Team:Bilkent_UNAM_Turkey'); |
- | text-decoration: none;
| + | |
- | }
| + | |
| | | |
- | a.sidebarlinks { | + | var href4 = document.createElement('a'); |
- | display: block;
| + | href4.setAttribute('href','http://www.bilkent.edu.tr'); |
- | width: 300px;
| + | |
- | font-size: 1.2em;
| + | |
- | text-align: center;
| + | |
- | background-color: #827B60;
| + | |
- | color: white !important;
| + | |
- | padding: 10px 0px 10px 0px;
| + | |
- | margin-bottom: 5px
| + | |
- | }
| + | |
| | | |
- | a.sidebarlinks:hover {
| + | var td1 = document.createElement('td'); |
- | background-color: #A0C544;
| + | var td2 = document.createElement('td'); |
- | color: white !important;
| + | var td3 = document.createElement('td'); |
- | }
| + | var td4 = document.createElement('td'); |
| + | var td5 = document.createElement('td'); |
| + | td5.setAttribute('width','110'); |
| + | td5.appendChild(document.createElement('g:plusone')); |
| | | |
- | a.timelinelinks {
| |
- | color: #7F5217 !important;
| |
- | }
| |
| | | |
- | a.timelinelinks:hover {
| + | href1.appendChild(image1); |
- | color: #A0C544 !important;
| + | href2.appendChild(image2); |
- | }
| + | href3.appendChild(image3); |
| + | href4.appendChild(image4); |
| | | |
- | #content {
| + | td1.appendChild(href1); |
- | padding: 6px;
| + | td2.appendChild(href2); |
- | padding-top: 1px;
| + | td3.appendChild(href3); |
- | }
| + | td4.appendChild(href4); |
| | | |
- | </style>
| |
- | <script type="text/javascript">
| |
- | var fh = document.getElementsByClassName("firstHeading")[0];
| |
- | fh.parentElement.removeChild(fh);
| |
- | var fh=document.getElementById("contentSub");
| |
- | fh.parentElement.removeChild(fh);
| |
- | </script>
| |
- | <!-- !END BILKENTCSS -->
| |
| | | |
| + | tr1.appendChild(td1); |
| + | tr1.appendChild(td5); |
| + | tr1.appendChild(td2); |
| + | tr1.appendChild(td3); |
| + | tr1.appendChild(td4); |
| | | |
- |
| + | table1.appendChild(tr1); |
- | </ul>
| + | |
- | </div>
| + | |
| | | |
- | </p><p>
| |
| | | |
| + | document.getElementById('top-section').appendChild(table1); |
| | | |
- | <div id="abstract">
| |
- | <br>
| |
- | <h1>Team:Bilkent UNAM Turkey/Safety</h1>
| |
| | | |
- | <p>To address potential safety issues with our project, we were asked by iGEM to answer the following questions:</p>
| + | //banner up to here |
- | <div id="container" style="width:100px">
| + | |
- | <table border="0">
| + | |
- | <tr>
| + | |
- | <td valign=top>
| + | |
- | <ol>
| + | |
- | <li><strong>Would the materials used in your project and/or your final product pose:
| + | |
- | </strong>
| + | |
- | <ul>
| + | |
- | a. Risks to the safety and health of team members or others in the lab?</li>
| + | |
| | | |
- | <p><p>Using hazardous materials always has risk to cause trouble for team and lab members. We always use hoods and wearing lab coat, gloves, goggles are essential for an experiment.
| |
- | We are working on two species one of them is Chlamydomonas reinhardtii which has no dangerous effect on human health. Other one is Bacillus subtilis which also is not human pathogen but it could cause food poisoning.</p>
| |
- | <br>
| |
- | <ul>
| |
- | b. Risks to the safety and health of the general public if released by design or accident?</li>
| |
| | | |
- | <p><p>Chlamydomonas reinhardtii is a strain of algae and it could cause algal bloom that means it overgrown in a water ecosystem and become poisonous for other species which share same places.
| |
- | According to a Toxic Substances Control Act report from the Environmental Protection Agency (EPA), Bacillus subtilis is considered “a benign organism as it does not possess traits that cause disease. It is not considered pathogenic or toxigenic to humans, animals, or plants. The potential risk associated with the use of this bacterium in fermentation facilities is low.” Its degree of toxicity is III and IV the lowest toxicity effect on other species.</p>
| |
- | <br>
| |
- | <ul>
| |
- | c. Risks to environmental quality if released by design or accident?</li>
| |
- | </ul>
| |
- | <p><p>We haven’t checked modified organism is more competitive than natural strains. However; Bacillus subtilis is well-known and commonly used model organism like Chlamydomonas reinhardtii.</p>
| |
- | <br>
| |
- | <ul>
| |
- | d. Risks to security through malicious misuse by individuals, groups or states?</li>
| |
- | </ul>
| |
- | <p><p>Our modified Chlamydomonas reinhardtii just degrade TNT and it could not use for terrorism activity. Those two modified organism could not have ability to damage human health. Our facility always has an active security system and it requires an identity card for enterance.</p>
| |
- | <br>
| |
| | | |
- | <br>
| |
- | <br>
| |
- | </li>
| |
- | <li><strong> Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
| |
- | </strong>
| |
- | <ul>
| |
- | <li> did you document these issues in the Registry? </li>
| |
- | <li> how did you manage to handle the safety issue? </li>
| |
| | | |
- | <li> How could other teams learn from your experience? </li>
| |
- | </ul>
| |
- | <br>
| |
- | <p>Groups which will use our parts should be consider resistance of transgenic algae. None of our parts raise any safety issues. In iNitroalgae Project, Clamydomonas reinhardtii experiments were done indoor of a BSL1 laboratory setting. Working with algae could be include transgenic plant policy to care about but we are not sure.
| |
- | <br>
| |
- | <br>
| |
- | </li>
| |
- | <li><strong>Is there a local biosafety group, committee, or review board at your institution? </strong>
| |
| | | |
- | <ul>
| |
- | <li> If yes, what does your local biosafety group think about your project? </li>
| |
- | <li> If no, which specific biosafety rules or guidelines do you have to consider in your country? </li>
| |
- | </ul>
| |
- | </li>
| |
| | | |
- | <br>
| |
- | <p>The <a href="http://www.nano.org.tr/index1.html"> National Nanotechnology Research Center </a>(UNAM) has a guidelines primarily focused on prpoerly disposing of biohazardous materials. We don’t require to contact to these group since, our project has usual techniques which is standard for cloning. All team members obey the rules during researches.</p><br>
| |
| | | |
- | <li><strong>Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? </strong></li>
| |
- | <br>
| |
| | | |
- | <p>The Registry of Standard Biological Parts include a set of safety process (e.g., proper storage, disposal, lab precautions, and so on.), when they got this parts they accept to take care about those cautions. Simple precautions could save really complicated harmful exposure. All team member should be informed about those safety regulations. </p> | + | var popdiv=" "; |
- | </p> | + | for(var i =0;i<list.length;i++){ |
| + | popdiv +="<DIV id=\"subcontent"+i+"\" class=\"pops\"></DIV>"; |
| + | } |
| + | $('.popingProblem').after(popdiv) |
| + | for(var i=0 ;i<list.length;i++) |
| + | dropdowncontent.init(("searchlink"+i), "right-bottom", 500, "mouseover"); |
| + | //Call dropdowncontent.init("anchorID", "positionString", glideduration, "revealBehavior") at the end of the page: |
| + | $('div').remove('.popingProblem',function(){ |
| + | for(var i=0 ;i<list.length;i++) |
| + | dropdowncontent.init(("searchlink"+i), "right-bottom", 500, "mouseover"); |
| + | //Call dropdowncontent.init("anchorID", "positionString", glideduration, "revealBehavior") at the end of the page: |
| + | }); |
| + | |
| + | </script> |
| + | |
| + | </html> |
There is a problem with poping up if you see this note.